MDM2 and chronic obstructive pulmonary disease: In conclusion, our findings position MDM2, FKBP5, and CTNNA1 as promising diagnostic biomarkers for COPD, reflecting certain aspects of the disease’s pathophysiology: dysregulated cellular stress response and inherent glucocorticoid signaling dysfunction.